Pegylated liposomal doxorubicin-induced hand-foot syndrome predicted by serum metabolomic profiling and prevented by calcium dobesilate - 17/02/22
Authors Song and Tian contributed equally to this article. |
|
Funding sources: Supported by Hebei Science and Technology Agency (17272604D), Natural Science Foundation of Hebei Province, China (H2020206365), Special Fund for Clinical Research of Wu Jieping Medical Foundation (320.6750.2020-07-17), and Beijing Xisike Clinical Oncology Research Foundation (Y-SY201901-0021). |
|
IRB approval status: Approved by the Scientific and Ethics Committees of Fourth Hospital of Hebei Medical University (Hebei, China). |
|
Reprints not available from the authors. |
Vol 86 - N° 3
P. 688-690 - mars 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?